{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:42:23Z","timestamp":1776944543296,"version":"3.51.4"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Impot Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Nonmedical anabolic\u2013androgenic steroid (AAS) use is increasingly encountered in sexual medicine practice, often presenting through sexual symptoms or fertility concerns rather than overt systemic illness. This review summarizes the major health consequences of AAS abuse with emphasis on sexual and reproductive sequelae and provides a pragmatic approach to evaluation and recovery after cessation. AAS exposure commonly suppresses the hypothalamo\u2013pituitary\u2013gonadal axis, leading to hypogonadism and hormonal imbalance that may manifest as reduced libido, erectile dysfunction, gynecomastia, and impaired spermatogenesis ranging from severe oligozoospermia to azoospermia. Recovery after discontinuation is heterogeneous: endocrine parameters frequently normalize earlier than semen parameters, and prolonged\/high-dose exposure is associated with delayed or incomplete recovery in a clinically meaningful subset. Beyond sexual and reproductive harm, convergent observational evidence supports increased cardiovascular risk (remodeling, dysfunction, and adverse events), hepatic injury (particularly with 17\u03b1-alkylated agents), hematologic\/prothrombotic changes, tendon pathology, neuropsychiatric symptoms, and dermatologic complications, with risk shaped by dose, duration, and polypharmacy. In the absence of robust randomized trials, management should prioritize AAS cessation and relapse prevention. Clinicians should actively screen for organ-specific sequelae and individualize follow-up based on symptom burden, hormonal status, fertility goals, and time since last exposure, with selective use of pharmacological induction of recovery when clinically appropriate.<\/jats:p>","DOI":"10.1038\/s41443-026-01272-1","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T09:50:23Z","timestamp":1776937823000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Health consequences of anabolic steroids: a sexual-medicine perspective"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-6241","authenticated-orcid":false,"given":"Ahmad","family":"Majzoub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1010-0609","authenticated-orcid":false,"given":"Onder","family":"Canguven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,23]]},"reference":[{"key":"1272_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1059473","volume":"13","author":"P Bond","year":"2022","unstructured":"Bond P, Smit DL, de Ronde W. Anabolic-androgenic steroids: How do they work and what are the risks? Front. Endocrinol. 2022;13:1059473.","journal-title":"Front. Endocrinol."},{"key":"1272_CR2","unstructured":"The Nobel Prize in Chemistry [Internet]. Nobel Prize Outreach 2025. 1939. Available from: https:\/\/www.nobelprize.org\/prizes\/chemistry\/1939\/summary\/."},{"key":"1272_CR3","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/bjp.2008.165","volume":"154","author":"AT Kicman","year":"2008","unstructured":"Kicman AT. Pharmacology of anabolic steroids. Br. J. Pharmacol. 2008;154:502\u201321.","journal-title":"Br. J. Pharmacol"},{"key":"1272_CR4","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.annepidem.2014.01.009","volume":"24","author":"D Sagoe","year":"2014","unstructured":"Sagoe D, Molde H, Andreassen CS, Torsheim T, Pallesen S. The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Ann. Epidemiol. 2014;24:383\u201398.","journal-title":"Ann. Epidemiol."},{"key":"1272_CR5","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1521-0391.2013.12118.x","volume":"23","author":"HG Pope Jr","year":"2014","unstructured":"Pope HG Jr, Kanayama G, Athey A, Ryan E, Hudson JI, Baggish A. The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am. J. Addict. 2014;23:371\u20137.","journal-title":"Am. J. Addict."},{"key":"1272_CR6","doi-asserted-by":"publisher","first-page":"43","DOI":"10.23736\/S0031-0808.22.04677-8","volume":"65","author":"M Esposito","year":"2023","unstructured":"Esposito M, Salerno M, Calvano G, Agliozzo R, Ficarra V, Sessa F, et al. Impact of anabolic androgenic steroids on male sexual and reproductive function: a systematic review. Panminerva Med. 2023;65:43\u201350.","journal-title":"Panminerva Med."},{"key":"1272_CR7","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/j.1610-0387.2007.06176.x","volume":"5","author":"B Melnik","year":"2007","unstructured":"Melnik B, Jansen T, Grabbe S. Abuse of anabolic-androgenic steroids and bodybuilding acne: an underestimated health problem. J. Dtsch. Dermatol. Ges. 2007;5:110\u20137.","journal-title":"J. Dtsch. Dermatol. Ges."},{"key":"1272_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s13011-023-00528-z","volume":"18","author":"HCB Henriksen","year":"2023","unstructured":"Henriksen HCB, Havnes IA, J\u00f8rstad ML, Bj\u00f8rnebekk A. Health service engagement, side effects and concerns among men with anabolic-androgenic steroid use: a cross-sectional Norwegian study. Subst. Abuse Treat. Prev. Policy. 2023;18:19.","journal-title":"Subst. Abuse Treat. Prev. Policy"},{"key":"1272_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/nyas.15187","volume":"1538","author":"B Grant","year":"2024","unstructured":"Grant B, Hyams E, Davies R, Minhas S, Jayasena CN. Androgen abuse: risks and adverse effects in men. Ann. N. Y. Acad. Sci. 2024;1538:56\u201370.","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"1272_CR10","unstructured":"Hall JE Reproductive and hormonal functions of the male (and function of the pineal gland). In: Hall JE, Hall ME, editors. Textbook of Medical Physiology. 14 ed. Philadelphia, USA: Elsevier; 2021. 1011-25."},{"key":"1272_CR11","doi-asserted-by":"publisher","first-page":"T41","DOI":"10.1530\/JOE-15-0113","volume":"226","author":"TM Plant","year":"2015","unstructured":"Plant TM. 60 years of neuroendocrinology: the hypothalamo-pituitary-gonadal axis. J. Endocrinol. 2015;226:T41\u201354.","journal-title":"J. Endocrinol."},{"key":"1272_CR12","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1210\/endrev\/bnab001","volume":"42","author":"DJ Handelsman","year":"2021","unstructured":"Handelsman DJ. Androgen misuse and abuse. Endocr. Rev. 2021;42:457\u2013501.","journal-title":"Endocr. Rev."},{"key":"1272_CR13","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1095\/biolreprod.111.092593","volume":"85","author":"GL Hammond","year":"2011","unstructured":"Hammond GL. Diverse roles for sex hormone-binding globulin in reproduction. Biol. Reprod. 2011;85:431\u201341.","journal-title":"Biol. Reprod."},{"key":"1272_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.steroids.2008.10.016","volume":"74","author":"AG Fragkaki","year":"2009","unstructured":"Fragkaki AG, Angelis YS, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities. applied modifications in the steroidal structure. Steroids. 2009;74:172\u201397.","journal-title":"Steroids"},{"key":"1272_CR15","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1210\/jc.2009-1579","volume":"95","author":"S Basaria","year":"2010","unstructured":"Basaria S. Androgen abuse in athletes: detection and consequences. J. Clin. Endocrinol. Metab. 2010;95:1533\u201343.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1272_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.yrtph.2010.02.001","volume":"57","author":"J van Amsterdam","year":"2010","unstructured":"van Amsterdam J, Opperhuizen A, Hartgens F. Adverse health effects of anabolic-androgenic steroids. Regul. Toxicol. Pharmacol. 2010;57:117\u201323.","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"1272_CR17","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.fertnstert.2014.02.002","volume":"101","author":"CD Rahnema","year":"2014","unstructured":"Rahnema CD, Lipshultz LI, Crosnoe LE, Kovac JR, Kim ED. Anabolic steroid-induced hypogonadism: diagnosis and treatment. Fertil. Steril. 2014;101:1271\u20139.","journal-title":"Fertil. Steril."},{"key":"1272_CR18","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1592\/phco.31.8.757","volume":"31","author":"EJ Ip","year":"2011","unstructured":"Ip EJ, Barnett MJ, Tenerowicz MJ, Perry PJ. The Anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy. 2011;31:757\u201366.","journal-title":"Pharmacotherapy"},{"key":"1272_CR19","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1159\/000333037","volume":"18","author":"A Hakansson","year":"2012","unstructured":"Hakansson A, Mickelsson K, Wallin C, Berglund M. Anabolic androgenic steroids in the general population: user characteristics and associations with substance use. Eur. Addict. Res. 2012;18:83\u201390.","journal-title":"Eur. Addict. Res."},{"key":"1272_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1249\/01.mss.0000210194.56834.5d","volume":"38","author":"AB Parkinson","year":"2006","unstructured":"Parkinson AB, Evans NA. Anabolic androgenic steroids: a survey of 500 users. Med. Sci. Sports Exerc. 2006;38:644\u201351.","journal-title":"Med. Sci. Sports Exerc."},{"key":"1272_CR21","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1550-2783-4-12","volume":"4","author":"J Cohen","year":"2007","unstructured":"Cohen J, Collins R, Darkes J, Gwartney D. A league of their own: demographics, motivations and patterns of use of 1955 male adult non-medical anabolic steroid users in the United States. J. Int. Soc. Sports Nutr. 2007;4:12.","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"1272_CR22","doi-asserted-by":"publisher","first-page":"e056445","DOI":"10.1136\/bmjopen-2021-056445","volume":"12","author":"JMX Amaral","year":"2022","unstructured":"Amaral JMX, Kimerg\u00e5rd A, Deluca P. Prevalence of anabolic steroid users seeking support from physicians: a systematic review and meta-analysis. BMJ Open. 2022;12:e056445.","journal-title":"BMJ Open."},{"key":"1272_CR23","doi-asserted-by":"publisher","first-page":"165","DOI":"10.5534\/wjmh.210021","volume":"40","author":"G Corona","year":"2022","unstructured":"Corona G, Rastrelli G, Marchiani S, Filippi S, Morelli A, Sarchielli E, et al. Consequences of anabolic-androgenic steroid abuse in males; sexual and reproductive perspective. World J. Mens. Health. 2022;40:165\u201378.","journal-title":"World J. Mens. Health"},{"key":"1272_CR24","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4103\/jhrs.jhrs_90_23","volume":"16","author":"PM Mulawkar","year":"2023","unstructured":"Mulawkar PM, Maheshwari PN, Gauhar V, Agrawal SG, Mohammed TO, Singh AG, et al. Use of anabolic-androgenic steroids and male fertility: a systematic review and meta-analysis. J. Hum. Reprod. Sci. 2023;16:268\u201385.","journal-title":"J. Hum. Reprod. Sci."},{"key":"1272_CR25","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1038\/sj.ijir.3901030","volume":"15","author":"R Shabsigh","year":"2003","unstructured":"Shabsigh R. Hypogonadism and erectile dysfunction: the role for testosterone therapy. Int. J. Impot. Res. 2003;15:S9\u201313.","journal-title":"Int. J. Impot. Res."},{"key":"1272_CR26","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1464-410X.2007.06756.x","volume":"99","author":"F Saad","year":"2007","unstructured":"Saad F, Grahl AS, Aversa A, Yassin AA, Kadioglu A, Moncada I, et al. Effects of testosterone on erectile function: implications for the therapy of erectile dysfunction. BJU Int. 2007;99:988\u201392.","journal-title":"BJU Int."},{"key":"1272_CR27","first-page":"256","volume":"11","author":"MR Samieinasab","year":"2015","unstructured":"Samieinasab MR, Shahraki MR, Samieinasab F, Najafi S. Influence of nandrolone decanoate administration on serum lipids and liver enzymes in rats. ARYA Atheroscler. 2015;11:256\u201360.","journal-title":"ARYA Atheroscler."},{"key":"1272_CR28","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1055\/s-0031-1297371","volume":"37","author":"G Lippi","year":"2011","unstructured":"Lippi G, Banfi G. Doping and thrombosis in sports. Semin. Thromb. Hemost. 2011;37:918\u201328.","journal-title":"Semin. Thromb. Hemost."},{"key":"1272_CR29","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1570159X13666141210222725","volume":"13","author":"D Piacentino","year":"2015","unstructured":"Piacentino D, Kotzalidis GD, Del Casale A, Aromatario MR, Pomara C, Girardi P, et al. Anabolic-androgenic steroid use and psychopathology in athletes. a systematic review. Curr. Neuropharmacol. 2015;13:101\u201321.","journal-title":"Curr. Neuropharmacol."},{"key":"1272_CR30","unstructured":"Swerdloff RS, Ng JCM Gynecomastia: Etiology, Diagnosis, and Treatment. South Dartmouth (MA): MDText.com, Inc.; 2023 [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279105\/."},{"key":"1272_CR31","doi-asserted-by":"publisher","first-page":"R102","DOI":"10.1530\/EC-19-0557","volume":"9","author":"W de Ronde","year":"2020","unstructured":"de Ronde W, Smit DL. Anabolic androgenic steroid abuse in young males. Endocr. Connect. 2020;9:R102\u2013r11.","journal-title":"Endocr. Connect."},{"key":"1272_CR32","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1055\/s-0043-1771293","volume":"56","author":"M Beniwal","year":"2023","unstructured":"Beniwal M, Singh K, Singh P, Sharma A, Beniwal S. The burden of anabolic androgenic steroid-induced gynecomastia. Indian. J. Plast. Surg. 2023;56:338\u201343.","journal-title":"Indian. J. Plast. Surg."},{"key":"1272_CR33","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/00006534-200101000-00039","volume":"107","author":"A Babigian","year":"2001","unstructured":"Babigian A, Silverman RT. Management of gynecomastia due to use of anabolic steroids in bodybuilders. Plast. Reconstr. Surg. 2001;107:240\u20132.","journal-title":"Plast. Reconstr. Surg."},{"key":"1272_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/SAR.S495789","volume":"16","author":"GS Mubarak","year":"2025","unstructured":"Mubarak GS, Bamagous GA, Alsanosi SM, Alhindi YZ, Alqashqari HS, Albar HT, et al. Abnormalities in blood parameters in athletes taking anabolic androgenic steroidal agents; an observational clinical study. Subst. Abuse Rehabil. 2025;16:1\u201312.","journal-title":"Subst. Abuse Rehabil."},{"key":"1272_CR35","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2022.978311","volume":"10","author":"O Berger","year":"2022","unstructured":"Berger O, Landau Z, Talisman R. Gynecomastia: a systematic review of pharmacological treatments. Front. Pediatr. 2022;10:978311.","journal-title":"Front. Pediatr."},{"key":"1272_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102318","volume":"67","author":"W de Ronde","year":"2022","unstructured":"de Ronde W, Smit DL. Anabolic-androgenic steroid abuse and testicular function in men; recent insights. Curr. Opin. Pharmacol. 2022;67:102318.","journal-title":"Curr. Opin. Pharmacol."},{"key":"1272_CR37","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1210\/jc.2008-1846","volume":"94","author":"Y Gu","year":"2009","unstructured":"Gu Y, Liang X, Wu W, Liu M, Song S, Cheng L, et al. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men. J. Clin. Endocrinol. Metab. 2009;94:1910\u20135.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1272_CR38","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/humrep\/deaa366","volume":"36","author":"DL Smit","year":"2021","unstructured":"Smit DL, Buijs MM, de Hon O, den Heijer M, de Ronde W. Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study. Hum. Reprod. 2021;36:880\u201390.","journal-title":"Hum. Reprod."},{"key":"1272_CR39","doi-asserted-by":"publisher","first-page":"dgz324","DOI":"10.1210\/clinem\/dgz324","volume":"105","author":"N Shankara-Narayana","year":"2020","unstructured":"Shankara-Narayana N, Yu C, Savkovic S, Desai R, Fennell C, Turner L, et al. Rate and extent of recovery from reproductive and cardiac dysfunction due to androgen abuse in men. J. Clin. Endocrinol. Metab. 2020;105:dgz324.","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"1272_CR40","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1097\/JU.0000000000004180","volume":"212","author":"RE Brannigan","year":"2024","unstructured":"Brannigan RE, Hermanson L, Kaczmarek J, Kim SK, Kirkby E, Tanrikut C. Updates to male infertility: AUA\/ASRM guideline (2024). J. Urol. 2024;212:789\u201399.","journal-title":"J. Urol."},{"key":"1272_CR41","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1007\/s00421-005-0111-7","volume":"96","author":"PP Pereira-Junior","year":"2006","unstructured":"Pereira-Junior PP, Chaves EA, Costa ESRH, Masuda MO, de Carvalho AC, Nascimento JH. Cardiac autonomic dysfunction in rats chronically treated with anabolic steroid. Eur. J. Appl. Physiol. 2006;96:487\u201394.","journal-title":"Eur. J. Appl. Physiol."},{"key":"1272_CR42","doi-asserted-by":"publisher","DOI":"10.3389\/frph.2021.732318","volume":"3","author":"DL Smit","year":"2021","unstructured":"Smit DL, Voogel AJ, den Heijer M, de Ronde W. Anabolic androgenic steroids induce reversible left ventricular hypertrophy and cardiac dysfunction. echocardiography results of the HAARLEM study. Front. Reprod. Health. 2021;3:732318.","journal-title":"Front. Reprod. Health"},{"key":"1272_CR43","doi-asserted-by":"publisher","first-page":"e2526636","DOI":"10.1001\/jamanetworkopen.2025.26636","volume":"8","author":"LF Buhl","year":"2025","unstructured":"Buhl LF, Christensen LL, Hjortebjerg R, Hasific S, Hjerrild C, Harders S, et al. Illicit anabolic steroid use and cardiovascular status in men and women. JAMA Netw. Open. 2025;8:e2526636.","journal-title":"JAMA Netw. Open."},{"key":"1272_CR44","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.124.071117","volume":"151","author":"J Windfeld-Mathiasen","year":"2025","unstructured":"Windfeld-Mathiasen J, Heerfordt IM, Dalhoff KP, Andersen JT, Andersen MA, Johansson KS, et al. Cardiovascular disease in anabolic androgenic steroid users. Circulation. 2025;151:828\u201334.","journal-title":"Circulation"},{"key":"1272_CR45","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.3748\/wjg.v28.i26.3071","volume":"28","author":"A Petrovic","year":"2022","unstructured":"Petrovic A, Vukadin S, Sikora R, Bojanic K, Smolic R, Plavec D, et al. Anabolic androgenic steroid-induced liver injury: an update. World J. Gastroenterol. 2022;28:3071\u201380.","journal-title":"World J. Gastroenterol."},{"key":"1272_CR46","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2174\/138955711795445916","volume":"11","author":"M Neri","year":"2011","unstructured":"Neri M, Bello S, Bonsignore A, Cantatore S, Riezzo I, Turillazzi E, et al. Anabolic androgenic steroids abuse and liver toxicity. Mini Rev. Med. Chem. 2011;11:430\u20137.","journal-title":"Mini Rev. Med. Chem."},{"key":"1272_CR47","first-page":"7","volume":"21","author":"R Solimini","year":"2017","unstructured":"Solimini R, Rotolo MC, Mastrobattista L, Mortali C, Minutillo A, Pichini S, et al. Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping. Eur. Rev. Med. Pharmacol. Sci. 2017;21:7\u201316.","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"1272_CR48","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1111\/j.1478-3231.2010.02346.x","volume":"31","author":"PA Schwingel","year":"2011","unstructured":"Schwingel PA, Cotrim HP, Salles BR, Almeida CE, dos Santos CR Jr, Nachef B, et al. Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease. Liver Int. 2011;31:348\u201353.","journal-title":"Liver Int."},{"key":"1272_CR49","doi-asserted-by":"publisher","first-page":"e240283","DOI":"10.1530\/EC-24-0283","volume":"13","author":"P Bond","year":"2024","unstructured":"Bond P, Verdegaal T, Smit DL. Testosterone therapy-induced erythrocytosis: can phlebotomy be justified? Endocr. Connect. 2024;13:e240283.","journal-title":"Endocr. Connect."},{"key":"1272_CR50","volume":"2014","author":"JE Mullen","year":"2014","unstructured":"Mullen JE, G\u00e5revik N, Schulze J, Rane A, Bergman LB, Ekstr\u00f6m L. Perturbation of the hematopoietic profile by anabolic androgenic steroids. J. Horm. 2014;2014:510257.","journal-title":"J. Horm."},{"key":"1272_CR51","doi-asserted-by":"publisher","first-page":"10374","DOI":"10.3390\/app122010374","volume":"12","author":"I Ivanov","year":"2022","unstructured":"Ivanov I. Hemorheological alterations and physical activity. Appl. Sci. 2022;12:10374.","journal-title":"Appl. Sci."},{"key":"1272_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.rpth.2023.102215","volume":"7","author":"E Camilleri","year":"2023","unstructured":"Camilleri E, Smit DL, van Rein N, Le Cessie S, de Hon O, den Heijer M, et al. Coagulation profiles during and after anabolic androgenic steroid use: data from the HAARLEM study. Res. Pract. Thromb. Haemost. 2023;7:102215.","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"1272_CR53","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.thromres.2024.04.027","volume":"238","author":"TS Fyksen","year":"2024","unstructured":"Fyksen TS, Seljeflot I, Vanberg P, Atar D, Halvorsen S. Platelet activity, coagulation, and fibrinolysis in long-term users of anabolic-androgenic steroids compared to strength-trained athletes. Thromb. Res. 2024;238:60\u20136.","journal-title":"Thromb. Res."},{"key":"1272_CR54","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.1177\/0363546515602010","volume":"43","author":"G Kanayama","year":"2015","unstructured":"Kanayama G, DeLuca J, Meehan WP 3rd, Hudson JI, Isaacs S, Baggish A, et al. Ruptured tendons in anabolic-androgenic steroid users: a cross-sectional cohort study. Am. J. Sports Med. 2015;43:2638\u201344.","journal-title":"Am. J. Sports Med."},{"key":"1272_CR55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.3390\/cells7120251","volume":"7","author":"V Guzzoni","year":"2018","unstructured":"Guzzoni V, Selistre-de-Ara\u00fajo HS, Marqueti RC. Tendon remodeling in response to resistance training, anabolic androgenic steroids and aging. Cells. 2018;7:251.","journal-title":"Cells"},{"key":"1272_CR56","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1177\/0363546506286867","volume":"34","author":"RC Marqueti","year":"2006","unstructured":"Marqueti RC, Parizotto NA, Chriguer RS, Perez SE, Selistre-de-Araujo HS. Androgenic-anabolic steroids associated with mechanical loading inhibit matrix metallopeptidase activity and affect the remodeling of the achilles tendon in rats. Am. J. Sports Med. 2006;34:1274\u201380.","journal-title":"Am. J. Sports Med."},{"key":"1272_CR57","volume":"17","author":"W \u017bywiec","year":"2025","unstructured":"\u017bywiec W, Dorota A, Koz\u0142owski K, Dorota M, Milczarek C, Koval I, et al. Impact of anabolic steroids on tendons: a narrative review. Cureus. 2025;17:e93649.","journal-title":"Cureus"},{"key":"1272_CR58","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3389\/fphys.2018.00190","volume":"9","author":"IV de Sousa Neto","year":"2018","unstructured":"de Sousa Neto IV, Durigan JLQ, Guzzoni V, Tibana RA, Prestes J, de Araujo HSS, et al. Effects of resistance training on matrix metalloproteinase activity in skeletal muscles and blood circulation during aging. Front. Physiol. 2018;9:190.","journal-title":"Front. Physiol."},{"key":"1272_CR59","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2337717","volume":"56","author":"B Karagun","year":"2024","unstructured":"Karagun B, Altug S. Anabolic-androgenic steroids are linked to depression and anxiety in male bodybuilders: the hidden psychogenic side of anabolic androgenic steroids. Ann. Med. 2024;56:2337717.","journal-title":"Ann. Med."},{"key":"1272_CR60","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/1403494820973096","volume":"49","author":"S Gestsdottir","year":"2021","unstructured":"Gestsdottir S, Kristjansdottir H, Sigurdsson H, Sigfusdottir ID. Prevalence, mental health and substance use of anabolic steroid users: a population-based study on young individuals. Scand. J. Public. Health. 2021;49:555\u201362.","journal-title":"Scand. J. Public. Health"},{"key":"1272_CR61","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.jsams.2017.03.008","volume":"20","author":"AS Lindqvist Bagge","year":"2017","unstructured":"Lindqvist Bagge AS, Ros\u00e9n T, Fahlke C, Ehrnborg C, Eriksson BO, Moberg T, et al. Somatic effects of AAS abuse: A 30-years follow-up study of male former power sports athletes. J. Sci. Med. Sport. 2017;20:814\u20138.","journal-title":"J. Sci. Med. Sport."},{"key":"1272_CR62","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101691","volume":"36","author":"A Sharma","year":"2022","unstructured":"Sharma A, Grant B, Islam H, Kapoor A, Pradeep A, Jayasena CN. Common symptoms associated with usage and cessation of anabolic androgenic steroids in men. Best. Pract. Res. Clin. Endocrinol. Metab. 2022;36:101691.","journal-title":"Best. Pract. Res. Clin. Endocrinol. Metab."},{"key":"1272_CR63","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1111\/ajad.13157","volume":"30","author":"HG Pope Jr","year":"2021","unstructured":"Pope HG Jr, Kanayama G, Hudson JI, Kaufman MJ. Review article: anabolic-androgenic steroids, violence, and crime: two cases and literature review. Am. J. Addict. 2021;30:423\u201332.","journal-title":"Am. J. Addict."},{"key":"1272_CR64","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1001\/archpsyc.63.11.1274","volume":"63","author":"F Kl\u00f6tz","year":"2006","unstructured":"Kl\u00f6tz F, Garle M, Granath F, Thiblin I. Criminality among individuals testing positive for the presence of anabolic androgenic steroids. Arch. Gen. Psychiatry. 2006;63:1274\u20139.","journal-title":"Arch. Gen. Psychiatry"},{"key":"1272_CR65","first-page":"579","volume":"6","author":"A Bj\u00f8rnebekk","year":"2021","unstructured":"Bj\u00f8rnebekk A, Kaufmann T, Hauger LE, Klonteig S, Hullstein IR, Westlye LT. Long-term anabolic-androgenic steroid use is associated with deviant brain aging. Biol. Psychiatry Cogn. Neurosci. Neuroimaging. 2021;6:579\u201389.","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"1272_CR66","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.drugalcdep.2015.04.023","volume":"152","author":"MJ Kaufman","year":"2015","unstructured":"Kaufman MJ, Janes AC, Hudson JI, Brennan BP, Kanayama G, Kerrigan AR, et al. Brain and cognition abnormalities in long-term anabolic-androgenic steroid users. Drug. Alcohol. Depend. 2015;152:47\u201356.","journal-title":"Drug. Alcohol. Depend."},{"key":"1272_CR67","doi-asserted-by":"publisher","first-page":"31","DOI":"10.3390\/forensicsci5030031","volume":"5","author":"MG Chisari","year":"2025","unstructured":"Chisari MG, Esposito M, Alloca S, Franco S, Francaviglia M, Volonnino G, et al. Anabolic\u2013androgenic steroids and brain damage: a review of evidence and medico-legal implications. Forensic Sci. 2025;5:31.","journal-title":"Forensic Sci."},{"key":"1272_CR68","doi-asserted-by":"publisher","first-page":"e43020","DOI":"10.2196\/43020","volume":"6","author":"G Furth","year":"2023","unstructured":"Furth G, Marroquin NA, Kirk J, Ajmal H, Szeto MD, Zueger M, et al. Cutaneous manifestations of anabolic-androgenic steroid use in bodybuilders and the dermatologist\u2019s role in patient care. JMIR Dermatol. 2023;6:e43020.","journal-title":"JMIR Dermatol."},{"key":"1272_CR69","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2298878","volume":"35","author":"JQ Del Rosso","year":"2024","unstructured":"Del Rosso JQ, Kircik L. The cutaneous effects of androgens and androgen-mediated sebum production and their pathophysiologic and therapeutic importance in acne vulgaris. J. Dermatol. Treat. 2024;35:2298878.","journal-title":"J. Dermatol. Treat."},{"key":"1272_CR70","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2147\/CCID.S35302","volume":"7","author":"KS Ibler","year":"2014","unstructured":"Ibler KS, Kromann CB. Recurrent furunculosis - challenges and management: a review. Clin. Cosmet. Investig. Dermatol. 2014;7:59\u201364.","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"key":"1272_CR71","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-019-0343-1","volume":"16","author":"G Bates","year":"2019","unstructured":"Bates G, Van Hout MC, Teck JTW, McVeigh J. Treatments for people who use anabolic androgenic steroids: a scoping review. Harm Reduct. J. 2019;16:75.","journal-title":"Harm Reduct. J."},{"key":"1272_CR72","unstructured":"BMJ Best Practice. Anabolic steroid use disorder [Internet]. BMJ Publishing Group. 2025. Available from: https:\/\/bestpractice.bmj.com\/topics\/en-gb\/987#:~:text=Summary,or%20to%20mask%20their%20use."},{"key":"1272_CR73","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1621558","volume":"16","author":"J van Os","year":"2025","unstructured":"van Os J, Smit DL, Bond P, de Ronde W. Prolonged post-androgen abuse hypogonadism: potential mechanisms and a proposed standardized diagnosis. Front. Endocrinol. 2025;16:1621558.","journal-title":"Front. Endocrinol."},{"key":"1272_CR74","doi-asserted-by":"publisher","first-page":"e0161208","DOI":"10.1371\/journal.pone.0161208","volume":"11","author":"JJ Rasmussen","year":"2016","unstructured":"Rasmussen JJ, Selmer C, \u00d8stergren PB, Pedersen KB, Schou M, Gustafsson F, et al. Former abusers of anabolic androgenic steroids exhibit decreased testosterone levels and hypogonadal symptoms years after cessation: a case-control study. PLoS One. 2016;11:e0161208.","journal-title":"PLoS One"},{"key":"1272_CR75","doi-asserted-by":"publisher","first-page":"e220097","DOI":"10.1530\/RAF-22-0097","volume":"4","author":"B Grant","year":"2023","unstructured":"Grant B, Pradeep A, Minhas S, Dhillo WS, Quinton R, Jayasena CN. Survey of endocrinologists managing recovery from anabolic androgenic steroid induced hypogonadism. Reprod. Fertil. 2023;4:e220097.","journal-title":"Reprod. Fertil."},{"key":"1272_CR76","doi-asserted-by":"publisher","DOI":"10.1016\/j.mex.2024.102810","volume":"13","author":"IA Havnes","year":"2024","unstructured":"Havnes IA, Henriksen HCB, Johansen PW, Bj\u00f8rnebekk A, Neupane SP, Hisdal J, et al. Off-label use of clomiphene citrate to treat anabolic androgenic steroid induced hypogonadism upon cessation among men (CloTASH) - A pilot study protocol. MethodsX. 2024;13:102810.","journal-title":"MethodsX"},{"key":"1272_CR77","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1016\/j.fertnstert.2023.09.016","volume":"120","author":"BR Ledesma","year":"2023","unstructured":"Ledesma BR, Weber A, Venigalla G, Muthigi A, Thomas J, Narasimman M, et al. Fertility outcomes in men with prior history of anabolic steroid use. Fertil. Steril. 2023;120:1203\u20139.","journal-title":"Fertil. Steril."},{"key":"1272_CR78","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4103\/aja.aja_101_19","volume":"22","author":"F Del Giudice","year":"2020","unstructured":"Del Giudice F, Busetto GM, De Berardinis E, Sperduti I, Ferro M, Maggi M, et al. A systematic review and meta-analysis of clinical trials implementing aromatase inhibitors to treat male infertility. Asian J. Androl. 2020;22:360\u20137.","journal-title":"Asian J. Androl."},{"key":"1272_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.drugalcdep.2008.05.004","volume":"98","author":"G Kanayama","year":"2008","unstructured":"Kanayama G, Hudson JI, Pope HG Jr. Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern? Drug. Alcohol. Depend. 2008;98:1\u201312.","journal-title":"Drug. Alcohol. Depend."}],"container-title":["International Journal of Impotence Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41443-026-01272-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-026-01272-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41443-026-01272-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:02:44Z","timestamp":1776942164000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41443-026-01272-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,23]]},"references-count":79,"alternative-id":["1272"],"URL":"https:\/\/doi.org\/10.1038\/s41443-026-01272-1","relation":{},"ISSN":["0955-9930","1476-5489"],"issn-type":[{"value":"0955-9930","type":"print"},{"value":"1476-5489","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,23]]},"assertion":[{"value":"28 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Due to the nature of the manuscript, no ethical approval was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}